About Anshul Specialty Molecules
Anshul Specialty Molecules is a company based in Mumbai (India). It operates as a B2B. The company has 205 employees. Anshul Specialty Molecules offers products and services including Oxalyl chloride, Chloromethyl isopropyl carbonate, Methyl oxalyl chloride, Hexachloroacetone, and N-Ethyl-5-Methyl-2-(1-Methylethyl)cyclohexane carboxamide. Anshul Specialty Molecules operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Mumbai, India
- Employees 205
- SectorsChemicals & Materials
- Email••••••••
- Website anshulchemicals.com
- Legal Name Anshul Specialty Molecules Private Limited
- Date of Incorporation 05 Oct, 1971
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹177 Cr
FY 2024 · +18% YoY
- Net Profit₹39.07 Cr
FY 2024 · 22% margin
- EBITDA₹52.36 Cr
FY 2024 · 30% margin
- Employee Count205
Associated legal entities of Anshul Specialty Molecules
Anshul Specialty Molecules is associated with 2 registered companies on The Company Check; the primary company is Anshul Specialty Molecules Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Anshul Specialty Molecules Private Limited CIN U24100MH1971PTC015364 | Active | 05 Oct 1971 | Mumbai, Maharashtra | ₹177 Cr | 205 | 5 | View details |
| Mibiome Therapeutics Llp CIN AAP-3186 | Active | 16 May 2019 | Mumbai, Maharashtra | $45,600 | – | 2 | View details |
Products & Services of Anshul Specialty Molecules
Anshul Specialty Molecules offers a comprehensive portfolio of products and services, including Oxalyl chloride, Chloromethyl isopropyl carbonate, Methyl oxalyl chloride, Hexachloroacetone, and N-Ethyl-5-Methyl-2-(1-Methylethyl)cyclohexane carboxamide.
Used in agro and pharma applications for synthesis processes.
Applied in pharma for Tenofavir disoproxilfumarate production.
Utilized in pharma and specialty chemical manufacturing.
Used in pharma for Sevoflurane and related applications.
Serves as a pharmaceutical coolant in formulation processes.
Applied in pharma and specialty chemical production.
Used in flavors, fragrances, and pharma like Salbutamol.
Employed in flavor and fragrance industry applications.
Utilized in pharma and specialty chemical formulations.
Applied in flavors and fragrances for various uses.
Used in flavors and fragrances for aromatic purposes.
Employed in flavors and fragrances industry sectors.
Applied in pharma for Tolvaptine and related compounds.
Used in pharma and specialty chemical applications.
Utilized in pharma and industrial chemical processes.
Applied in pharma and specialty chemical production.
Used in pharma for compounds like Carmustine.
Employed in pharma and specialty chemical synthesis.
Applied in pharma for various synthesis applications.
Used in pharma and specialty chemical formulations.
Utilized in pharma and chemical synthesis processes.
Applied in agro and pharma chemical applications.
Used in industrial and performance chemical sectors.
Employed in industrial and performance applications.
Utilized in industrial and performance chemical uses.
Applied in industrial and performance chemical fields.
Used in industrial and performance chemical applications.
Board of directors of Anshul Specialty Molecules Private Limited (Anshul Specialty Molecules)
Anshul Specialty Molecules Private Limited is the primary company behind Anshul Specialty Molecules. The boards of the 2 registered companies of Anshul Specialty Molecules currently have 6 directors; the longest-serving is Ashwin Champraj Shroff, appointed in 2014. 11 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ashwin Champraj Shroff DIN 00019952 | Director | 14 Nov 2014 | 11 yrs 10 mo | Anshul Specialty Molecules Private Limited |
| Ravi Ashwin Shroff DIN 00033505 | Designated Partner | 16 May 2019 | 7 yrs 4 mo | Mibiome Therapeutics Llp, Anshul Specialty Molecules Private Limited |
| Gautam Das DIN 08961168 | Designated Partner | 14 Nov 2020 | 5 yrs 10 mo | Mibiome Therapeutics Llp |
| Shirish Ramchandra Satpute DIN 09457533 | Whole-time director | 01 Apr 2022 | 4 yrs 6 mo | Anshul Specialty Molecules Private Limited |
| Ramchandra Neelkanth Bhogale DIN 00292417 | Director | 27 Nov 2025 | 10 mo | Anshul Specialty Molecules Private Limited |
| Hrishit Ashwin Shroff DIN 00033693 | Director | 27 Nov 2025 | 10 mo | Anshul Specialty Molecules Private Limited |
Financials of Anshul Specialty Molecules
Figures of Anshul Specialty Molecules Private Limited, the primary company behind Anshul Specialty Molecules, for FY 2024. Revenue was ₹177 Cr (+18% year on year). Net profit was ₹39.07 Cr (22% margin). EBITDA was ₹52.36 Cr (30% margin). Revenue has grown at a compounded annual rate of +11% over three years and +12% over five years.
- ₹177 CrRevenue · FY 2024 · +18% YoY
- ₹39.07 CrNet profit · 22% margin
- ₹52.36 CrEBITDA · 30% margin
- ₹29.4 LakhPaid-up capital
- 205Employees (provident fund records)
- +11%Revenue CAGR, 3 years
- +12%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Anshul Specialty Molecules Private Limited are on its company page.
Detailed financial statements for Anshul Specialty Molecules
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Anshul Specialty Molecules
Anshul Specialty Molecules operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| provepharm.com | 1998 | Marseille, France | $145.93M | – | APIs and drug products are developed and valorized in pharmaceuticals. | |
| biostar-pharm.com | 2002 | Beijing, China | $135.23M | – | APIs, intermediates, and biochemical reagents are developed and manufactured. | |
| sequent.in | 2002 | Bengaluru, India | – | – | APIs are developed and manufactured for therapeutic areas. | |
| sterlingpharmasolutions.com | 2016 | Dudley, United Kingdom | – | 560 | Contract development, manufacturing, and analytical services for APIs are offered. | |
| snapdragonchemistry.com | 2014 | Cambridge, United States | – | 43 | Drug discovery and development service provider | |
| jubilantpharma.com | 1978 | Noida, India | – | – | Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | |
| hikal.com | 1988 | Mumbai, India | – | 355 | APIs and intermediates are produced via custom synthesis and research. |
Detailed competitors of Anshul Specialty Molecules
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Anshul Specialty Molecules
The website of Anshul Specialty Molecules (anshulchemicals.com) receives about 1.9K visits a month.
- Monthly visits1.9K
▲ 31% vs previous month
Similar companies to Anshul Specialty Molecules
10 companies that operate in the same segment as Anshul Specialty Molecules (Industrial & Functional Materials), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Major automotive components are manufactured and supplied by Hexion. | 2005 | Columbus, Ohio, United States | USD 15.26 M | – | – | |
Additives, silanes, and related formulations are manufactured globally. | 2010 | Schenectady, New York, United States | USD 804.95 K | USD 105.46 M | 491 | |
Pulp and paper products are manufactured by Suzano worldwide. | 1924 | Sao Paulo, Brazil | – | USD 9.15 B | 56,000 | |
Cellulose, biopackaging, and consumer tissue products are manufactured sustainably. | 1920 | Santiago, Region Metropolitana De Santiago, Chile | – | – | 15,490 | |
Chemicals, polymers, fabrics, and fibers are manufactured for apparel. | 2003 | Wichita, Kansas, United States | – | – | – | |
Paper and packaging products are manufactured for various applications. | 1888 | Verona, Veneto, Italy | – | – | – | |
Manufacturing of FIBC bags, container liners, and packaging solutions. | 2007 | Vadodara, Gujarat, India | – | USD 99.18 M | 615 | |
Colors and masterbatches are manufactured for industrial applications. | 1937 | Lambertville, United States | – | – | – | |
Packaging solutions and eco-friendly paper products are manufactured. | 2010 | Madawaska, Maine, United States | – | – | – | |
Acrylic fibers are produced by Pasupati Acrylon in India. | 1990 | Delhi, Delhi, India | – | USD 107.44 M | 514 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Anshul Specialty Molecules
Anshul Specialty Molecules is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Anshul Specialty Molecules has 205 employees.
The primary company behind Anshul Specialty Molecules, Anshul Specialty Molecules Private Limited, reported revenue of ₹177 Cr for FY 2024, up 18% year on year.
Anshul Specialty Molecules Private Limited manufactures specialty chemicals, including intermediates for active pharmaceutical ingredients and ingredients for flavors and fragrances. They provide custom synthesis and contract manufacturing services from facilities in Roha, Maharashtra, and Vadodara, India. As part of the Excel group, they serve global industries like pharma and agrochemicals, focusing on quality and innovation in chemical production.
Anshul Specialty Molecules's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Anshul Specialty Molecules offers Oxalyl chloride, Chloromethyl isopropyl carbonate, Methyl oxalyl chloride, Hexachloroacetone, and 6 more products and services.
Anshul Specialty Molecules is associated with 2 legal entities: Anshul Specialty Molecules Private Limited, Mibiome Therapeutics Llp.
The legal entities of Anshul Specialty Molecules currently have 6 directors, including Gautam Das, Ravi Ashwin Shroff, Ashwin Champraj Shroff and others.